<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In addition, a blank emulsion (BE) and a buccal Mygliol
 <sup class="sup">®</sup> 812 (a medium chain triglyceride mixture of capric and caprilic fatty acids) emulsion (BME), based on the same method, were also produced for use in the in vitro mucoadhesive and the antifungal/biocompatibility studies, respectively. The BE formulation was composed by bullfrog oil (14%), distilled water (80%) and surfactant blend (Tween
 <sup class="sup">®</sup> 20 and Span
 <sup class="sup">®</sup> 80 at proportion of 1.72:1 
 <italic class="italic">w</italic>/
 <italic class="italic">w</italic>) (6%). On the other hand, the BME and the BBE have similar composition (
 <xref rid="pharmaceutics-10-00257-t001" ref-type="table" class="xref">Table 1</xref>).
</p>
